The Western Cape’s healthcare industry is expanding, driven by economic growth, technological innovation with Cape Town ...

Cash and Cash Equivalents: based on the current operating plan and financial projections, Nanobiotix anticipates that the cash and cash equivalents of €39.8 million as of March 31, 2025, will fund its ...

Biotechnology has become the backbone of data-driven healthcare. With this advancement comes significant ethical and security ...

Alicia Alford, a recent graduate of the BULLS Life Sciences Academy and Durham Technical Community College, said Accelerate NC had helped her get her new “big girl job” as a Manufacturing Associate I ...

Satsuma, a unit of a Japanese drugmaker with U.S. headquarters in Durham, said its treatment, called Atzumi, received its new ...

CRISPR-edited iPSCs uncover early mitochondrial defects shared across ALS mutations, revealing pathways that could guide future treatments.

For the past 18 months, Heacock has been leading and teaching students how to brew beer in the new pilot plant that was completed and added to campus in 2022. He has also partnered with different ...

The Wasatch Ultra Growth Fund—Investor Class underperformed the benchmark with a return of -14.81%. Read more here.

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

Learn more about whether Alvotech or Arrowhead Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In March, 23andMe said that it was looking to sell “substantially all of its assets” through a court-approved reorganization plan.

Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...